Literature DB >> 30935882

Interstitial lung abnormalities: ignotum per ignotius.

Katerina M Antoniou1, Vasilios Tzilas2, Eirini Vasarmidi1, Emmanouil K Symvoulakis3, Argyris Tzouvelekis2, Demosthenes Bouros4.   

Abstract

Entities:  

Year:  2019        PMID： 30935882     DOI： 10.1016/S2213-2600(19)30052-9

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  2 in total

Review 1.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablation.

Authors:  Henry S Park; Frank C Detterbeck; David C Madoff; Brett C Bade; Ulas Kumbasar; Vincent J Mase; Andrew X Li; Justin D Blasberg; Gavitt A Woodard; Whitney S Brandt; Roy H Decker
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

2.  Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study.

Authors:  Katerina Antoniou; Katerina Markopoulou; Argyrios Tzouvelekis; Athina Trachalaki; Eirini Vasarmidi; Jiannis Organtzis; Vasilios Tzilas; Evangelos Bouros; Georgia Kounti; Christina Rampiadou; Serafeim-Chrysovalantis Kotoulas; Fotini Bardaka; Eleni Bibaki; Evangelia Fouka; Georgios Meletis; Stavros Tryfon; Zoe Daniil; Despina Papakosta; Demosthenes Bouros
Journal:  ERJ Open Res       Date:  2020-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.